President Trump has imposed temporary freezes at the National Institutes of Health on meetings, travel, communications and ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
and the Food and Drug Administration (FDA), as well as the National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS), which is responsible for the Medicare and ...
The Inflation Reduction Act (IRA), passed in 2022, made changes to the way drugs are covered and reimbursed in Medicare.
The first few weeks of the new Trump administration have been chaotic for science policy. With so much happening, it can be ...
Federal legislation to increase access to multi-cancer early detection technology for seniors through Medicare coverage is ...
Donald Trump’s second term brings major health care shifts with RFK Jr. leading HHS and deregulatory changes ahead. industry ...
RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.
Of the scores of day-one executive orders (EOs) issued by President Trump, the order rescinding a Biden administration executive order on ...
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process of negotiating prices for certain Medicare Part D drugs with input ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results